SCHEMBL2991624

SCHEMBL2991624

O=C(NC1CC1)c1cccnc1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
GAA P10253 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CNR2 P34972 3/20 0.53
CNR1 P21554 2/20 0.53
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMYD3 Q9H7B4 2/20 0.48
MAPK8 P45983 1/20 0.48
PDE4B Q07343 1/20 0.47
CYP46A1 Q9Y6A2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2982729 0.87 CNR1 (0.51) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL2987865 0.84 KLK7 (0.55) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL2993999 0.81 KMT2A (0.57) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL10969548 0.79 RORB (0.60) ALDH1A1KDM4EKMT2ASMN1; SMN2LMNA
SCHEMBL2992641 0.77 SLC6A12 (0.55) ALDH1A1GAAMEN1KMT2ASMN1; SMN2
SCHEMBL2992551 0.77 KMT2A (0.50) ALDH1A1GAAMEN1KMT2ASMN1; SMN2
SCHEMBL7745858 0.77 ALDH1A1 (0.57) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL12709415 0.77 P2RX7 (0.61) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL31583752 0.77 P2RX7 (0.58) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL2071080 0.77 MAP4K4 (0.47) ALDH1A1GAAKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173888-A1 Nicotinamide Derivatives PFIZER INC 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173888-A1 Nicotinamide Derivatives NNT, NAMPT, NQO1 ALDH1A1 172/4885GAA 887/4885KDM4E 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.